|
|
||||||||
The Annals of Thoracic Surgery, Vol 46, 603-610, Copyright © 1988 by The Society of Thoracic Surgeons
T Naruke, T Goya, R Tsuchiya and K Suemasu
In the past 25 years, 1,654 patients with non-small cell cancer underwent
resection at National Cancer Center Hospital, Tokyo. A comparative study
has been made of 5-year survival of patients who had pulmonary resection
with and without mediastinal lymph node dissection. There were 426 patients
(25.8% of the total) with N2 M0 disease. Of these, 345 underwent pulmonary
resection with mediastinal lymph node dissection. The 5-year survival in
this group was 15.9% (T1 N2 M0, 30.0%; T2 N2 M0, 14.5%; and T3 N2 M0,
12.9%). In the remaining 81 patients, who did not have mediastinal lymph
node dissection, 5-year survival was 6.7%. Of the 426 patients with N2 M0
disease, 242 were select patients who underwent a curative operation with
an overall 5- year survival of 19.2%. Sixty-six of them had squamous cell
carcinoma and a 5-year survival of 30.8%; 153 had adenocarcinoma and a
survival of 16.0%; 14 had large cell carcinoma and a survival of 12.8%; and
9 had adenosquamous cell carcinoma, and none survived 5 years. To improve
the end results, it is important to perform as many curative operations
with mediastinal lymph node dissection as possible. Histological cell type
and tumor status must be taken into consideration.
ARTICLES
The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis
Department of Surgery, National Cancer Center Hospital, Tokyo, Japan.
This article has been cited by other articles:
![]() |
P. Misthos, E. Sepsas, J. Kokotsakis, I. Skottis, and A. Lioulias The Significance of One-Station N2 Disease in the Prognosis of Patients With Nonsmall-Cell Lung Cancer Ann. Thorac. Surg., November 1, 2008; 86(5): 1626 - 1630. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Kang, Y. J. Ra, Y. T. Kim, S.-H. Jheon, S.-w. Sung, and J. H. Kim The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer. Ann. Thorac. Surg., October 1, 2008; 86(4): 1092 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. McMahon, C. Y. Kong, B. E. Johnson, M. C. Weinstein, J. C. Weeks, K. M. Kuntz, J.-A. O. Shepard, S. J. Swensen, and G. S. Gazelle Estimating Long-term Effectiveness of Lung Cancer Screening in the Mayo CT Screening Study Radiology, July 1, 2008; 248(1): 278 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sakuraba, H. Miyamoto, S. Oh, K. Shiomi, S. Sonobe, N. Takahashi, K. Imashimizu, and Y. Sakao Video-assisted thoracoscopic lobectomy vs. conventional lobectomy via open thoracotomy in patients with clinical stage IA non-small cell lung carcinoma Interactive CardioVascular and Thoracic Surgery, October 1, 2007; 6(5): 614 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muraoka, S. Akamine, T. Oka, T. Tagawa, A. Nakamura, T. Tsuchiya, T. Hayashi, and T. Nagayasu Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 356 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Takeda, H. Maeda, T. Okada, T. Yamaguchi, M. Nakagawa, S. Yokota, N. Sawabata, and M. Ohta Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer. Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 184 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nakano, K. Miyauchi, A. Horiuchi, and K. Kawachi Combined mediastinal node assessment by lymphadenectomy and intraoperative mediastinoscopy Interactive CardioVascular and Thoracic Surgery, August 1, 2005; 4(4): 374 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Casali, A. Stefani, P. Natali, G. Rossi, and U. Morandi Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 33 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. DeCamp Jr., S. Ashiku, and R. Thurer The Role of Surgery in N2 Non-Small Cell Lung Cancer Clin. Cancer Res., July 1, 2005; 11(13): 5033s - 5037s. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohtsuka, H. Nomori, H. Horio, T. Naruke, and K. Suemasu Is Major Pulmonary Resection by Video-Assisted Thoracic Surgery an Adequate Procedure in Clinical Stage I Lung Cancer? Chest, May 1, 2004; 125(5): 1742 - 1746. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Misthos, E. Sepsas, K. Athanassiadi, S. Kakaris, and I. Skottis Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 502 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakagawa, Y. Minamiya, Y. Katayose, H. Saito, K. Taguchi, H. Imano, H. Watanabe, K. Enomoto, M. Sageshima, T. Ueda, et al. A novel method for sentinel lymph node mapping using magnetite in patients with non-small cell lung cancer J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 563 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Choi, Y. M. Shim, J. Kim, and K. Kim Recurrence-free survival and prognostic factors in resected pN2 non-small cell lung cancer Eur. J. Cardiothorac. Surg., November 1, 2002; 22(5): 695 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nomori, H. Horio, T. Naruke, H. Orikasa, K. Yamazaki, and K. Suemasu Use of technetium-99m tin colloid for sentinel lymph node identification in non-small cell lung cancer J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 486 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pottgen, W. Eberhardt, S. Bildat, G. Stuben, G. Stamatis, L. Hillejan, S. Sohrab, H. Teschler, S. Seeber, H. Sack, et al. Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trial Ann. Onc., March 1, 2002; 13(3): 403 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Trodella, P. Granone, S. Valente, A. Turriziani, G. Macis, G. M. Corbo, S. Margaritora, A. Cesario, R. M. D'Angelillo, G. Gualano, et al. Phase I Trial of Weekly Gemcitabine and Concurrent Radiotherapy in Patients With Inoperable Non-Small-Cell Lung Cancer J. Clin. Oncol., February 1, 2002; 20(3): 804 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Deslauriers Current surgical treatment of nonsmall cell lung cancer 2001 Eur. Respir. J., February 1, 2002; 19(35_suppl): 61S - 70s. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Depierre, B. Milleron, D. Moro-Sibilot, S. Chevret, E. Quoix, B. Lebeau, D. Braun, J.-L. Breton, E. Lemarie, S. Gouva, et al. Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non-Small-Cell Lung Cancer J. Clin. Oncol., January 1, 2002; 20(1): 247 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ohta, M. Oda, J. Wu, Y. Tsunezuka, M. Hiroshi, A. Nonomura, and G. Watanabe Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 900 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Roviaro, F. Varoli, A. Romanelli, C. Vergani, and M. Maciocco Complications of tracheal sleeve pneumonectomy: Personal experience and overview of the literature J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 0234 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Andre, D. Grunenwald, J.-P. Pignon, A. Dujon, J. L. Pujol, P. Y. Brichon, L. Brouchet, E. Quoix, V. Westeel, and T. Le Chevalier Survival of Patients With Resected N2 Non-Small-Cell Lung Cancer: Evidence for a Subclassification and Implications J. Clin. Oncol., August 16, 2000; 18(16): 2981 - 2989. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tanaka, K. Yanagihara, Y. Otake, R. Miyahara, Y. Kawano, T. Nakagawa, T. Shoji, and H. Wada Surgery for non-small cell lung cancer: postoperative survival based on the revised tumor-node-metastasis classification and its time trend Eur. J. Cardiothorac. Surg., August 1, 2000; 18(2): 147 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka Induction Therapy for Non-small Cell Lung Cancer With Involved Mediastinal Nodes in Multiple Stations Chest, July 1, 2000; 118(1): 123 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Sawyer, J. A. Bonner, P. M. Gould, R. L. Foote, C. Deschamps, C. M. Lange, and H. Li Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma Ann. Thorac. Surg., October 1, 1999; 68(4): 1171 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Kernstine, W. Stanford, B. F. Mullan, N. P. Rossi, B. H. Thompson, D. L. Bushnell, K. A. McLaughlin, and J. A. Kern PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma Ann. Thorac. Surg., September 1, 1999; 68(3): 1022 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka PROGNOSIS OF COMPLETELY RESECTED pN2 NON-SMALL CELL LUNG CARCINOMAS: WHAT IS THE SIGNIFICANT NODE THAT AFFECTS SURVIVAL? J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 270 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pagni, A. McKelvey, C. Riordan, J. A. Federico, and R. B. Ponn Pulmonary resection for malignancy in the elderly: is age still a risk factor? Eur. J. Cardiothorac. Surg., July 1, 1999; 14(1): 40 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suzuki, K. Nagai, J. Yoshida, M. Nishimura, K. Takahashi, and Y. Nishiwaki THE PROGNOSIS OF SURGICALLY RESECTED N2 NON-SMALL CELL LUNGCANCER: THE IMPORTANCE OF CLINICAL N STATUS J. Thorac. Cardiovasc. Surg., July 1, 1999; 118(1): 145 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Maruyama, K. Sugio, T. Mitsudomi, G. Saitoh, T. Ishida, and K. Sugimachi RELATIONSHIP BETWEEN EARLY RECURRENCE AND MICROMETASTASES IN THE LYMPH NODES OF PATIENTS WITH STAGE I NON-SMALL-CELL LUNG CANCER J. Thorac. Cardiovasc. Surg., October 1, 1997; 114(4): 535 - 543. [Abstract] [Full Text] |
||||
![]() |
J. F. Vansteenkiste, P. R. De Leyn, G. J. Deneffe, G. Stalpaert, K. L. Nackaerts, T. E. Lerut, and M. G. Demedts Survival and Prognostic Factors in Resected N2 Non-Small Cell Lung Cancer: A Study of 140 Cases Ann. Thorac. Surg., May 1, 1997; 63(5): 1441 - 1450. [Abstract] [Full Text] |
||||
![]() |
J. R. Izbicki, B. Passlick, S. B. Hosch, B. Kubuschock, C. Schneider, C. Busch, W. T. Knoefel, O. Thetter, and K. Pantel MODE OF SPREAD IN THE EARLY PHASE OF LYMPHATIC METASTASIS IN NON-SMALL-CELL LUNG CANCER: SIGNIFICANCE OF NODAL MICROMETASTASIS J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 623 - 630. [Abstract] [Full Text] |
||||
![]() |
H. Akamatsu, M. Terashima, T. Koike, T. Takizawa, and Y. Kurita Staging of Primary Lung Cancer by Computed Tomography-Guided Percutaneous Needle Cytology of Mediastinal Lymph Nodes Ann. Thorac. Surg., August 1, 1996; 62(2): 352 - 355. [Abstract] [Full Text] |
||||
![]() |
J. R. Izbicki, B. Passlick, O. Karg, C. Bloechle, K. Pantel, W. T. Knoefel, and O. Thetter Impact of Radical Systematic Mediastinal Lymphadenectomy on Tumor Staging in Lung Cancer Ann. Thorac. Surg., January 1, 1995; 59(1): 209 - 214. [Abstract] [Full Text] |
||||
![]() |
T. Funatsu, Y. Matsubara, S. Ikeda, R. Hatakenaka, T. Hanawa, and H. Ishida Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 321 - 328. [Abstract] [Full Text] |
||||
![]() |
T. Yano, H. Yokoyama, T. Inoue, H. Asoh, K. Tayama, and Y. Ichinose Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lungSignificance of N1 level: lobar or hilar nodes J. Thorac. Cardiovasc. Surg., June 1, 1994; 107(6): 1398 - 1402. [Abstract] [Full Text] |
||||
![]() |
R. Rosell, J. Gomez-Codina, C. Camps, J. Maestre, J. Padille, A. Canto, J. L. Mate, S. Li, J. Roig, A. Olazabal, et al. A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer N. Engl. J. Med., January 20, 1994; 330(3): 153 - 158. [Abstract] [Full Text] |
||||
![]() |
G. C. Roviaro, F. Varoli, C. Rebuffat, S. M. Scalambra, C. Vergani, E. Sibilla, L. Palmarini, and G. Pezzuoli Tracheal sleeve pneumonectomy for bronchogenic carcinoma J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 13 - 18. [Abstract] [Full Text] |
||||
![]() |
P. Goldstraw, G. C. Mannam, D. K. Kaplan, and P. Michail Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease) J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 19 - 28. [Abstract] [Full Text] |
||||
![]() |
T. Funatsu The role of mediastinoscopic biopsy in preoperative assessment of lung cancer J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 309 - 311. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |